Scope
NICE guideline NG109 covers antimicrobial prescribing for lower urinary tract infection (UTI) in four groups: non-pregnant women, pregnant women, men, and children and young people under 16. It addresses self-care, back-up versus immediate prescribing, urine culture and review of results, safety-net advice for patients, reassessment and referral, and asymptomatic bacteriuria. It gives first- and second-choice antibiotics, with doses and course lengths, for non-pregnant women, pregnant women and children. For men, it specifies first-choice regimens only. Second-line management in men means considering alternative diagnoses and choosing an antibiotic guided by culture results; no second-line regimen is specified. Pyelonephritis and complicated UTI are directed to separate NICE guidance.
Written by House with AI assistance · AI-assisted source check 29 October 2026.
This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.
Self-care
- Give everyone with lower UTI self-care advice. This covers paracetamol for pain, or ibuprofen if preferred and suitable, and drinking enough fluids to avoid dehydration. No evidence was found for cranberry products or urine alkalinising agents as treatment. [1]
Prescribing strategy and urine testing
- For non-pregnant women, consider either a back-up prescription or an immediate prescription. The back-up prescription is for use if symptoms have not begun improving within 48 hours, or if they worsen at any time. Weigh the following: - Symptom severity. - Complication risk, which is higher with structural or functional genitourinary abnormality or immunosuppression. - Previous culture results. - Previous antibiotic use. - The woman's preferences. [1]
- Offer pregnant women and men an immediate antibiotic prescription. Before antibiotics are taken, obtain a midstream urine sample and send it for culture and susceptibility testing. [1]
- In under-16s, obtain urine before antibiotics are taken. Dipstick it or send it for culture, in line with the NICE under-16s UTI guideline. Manage febrile children under 5 according to the NICE fever in under 5s guideline. Offer an immediate antibiotic prescription. [1]
- This applies to non-pregnant women, men, and children and young people who were given antibiotics after urine was sent for culture. Review the choice when results arrive. Change the antibiotic if the bacteria are resistant and symptoms are not already improving. Use a narrow-spectrum antibiotic wherever possible. [1]
- In pregnancy, change the antibiotic if culture shows resistance, whether or not symptoms are improving. Use a narrow-spectrum antibiotic wherever possible. The committee cited the greater risk from UTI in pregnancy. [1]
Patient advice, reassessment and referral
- With a back-up prescription, explain the following: - Antibiotics are not needed immediately. - Use the prescription if there is no improvement within 48 hours, or if symptoms worsen at any time. - Diarrhoea and nausea are possible adverse effects. - Seek medical help if antibiotics are taken and symptoms then worsen rapidly or significantly, do not improve within 48 hours, or the person becomes systemically very unwell. [1]
- With an immediate prescription, warn about diarrhoea and nausea. Advise seeking medical help if symptoms worsen rapidly or significantly, do not improve within 48 hours, or the person becomes systemically very unwell. [1]
- Reassess if symptoms worsen rapidly or significantly, or have not begun improving within 48 hours of starting antibiotics. Take account of: - Other possible diagnoses. - Signs of more serious illness, such as pyelonephritis. - Previous antibiotic use. Send urine for culture if not already done, and review treatment once results are available. Refer people aged 16 and over to hospital if features suggest a more serious illness, such as sepsis. Refer children in line with the NICE under-16s UTI guideline. [1]
Asymptomatic bacteriuria
- Asymptomatic bacteriuria means more than 10^5 colony forming units/ml in the urine without UTI symptoms. It is not routinely screened for or treated in non-pregnant women, men, young people or children. [1]
- Offer pregnant women with asymptomatic bacteriuria an immediate antibiotic, because it is a risk factor for pyelonephritis and premature delivery. Choose nitrofurantoin, amoxicillin or cefalexin according to recent culture and susceptibility results, as a 7-day course. The same cautions apply as for symptomatic UTI: - Avoid nitrofurantoin at term, because of the risk of neonatal haemolysis. - Nitrofurantoin is not recommended if eGFR is below 45 ml/minute. - Use amoxicillin only if culture results show susceptibility. [1]
Antibiotic choice: general principles and non-pregnant women
- When choosing an antibiotic, take account of local resistance data and of previous cultures and prescribing. Use the population-specific tables. For symptoms of pyelonephritis or a complicated UTI, use the NICE acute pyelonephritis guideline instead. [1]
- Nitrofurantoin is not recommended when eGFR is below 45 ml/minute. It may be used with caution at 30–44 ml/minute, but only for uncomplicated lower UTI caused by suspected or proven multidrug-resistant bacteria, and only if benefit outweighs risk. Follow MHRA advice on monitoring for pulmonary and hepatic reactions. [1]
- First choices for non-pregnant women aged 16 and over: - Nitrofurantoin, if eGFR is 45 ml/minute or more: 100 mg modified-release twice daily, or 50 mg four times daily if modified-release is unavailable. - Trimethoprim, if resistance risk is low: 200 mg twice daily for 3 days. A 3-day course is sufficient at any age. [1]
- A lower risk of trimethoprim resistance is more likely in these situations: - No trimethoprim use in the past 3 months. - A previous culture suggested susceptibility, but trimethoprim was not used. - Younger people in areas where local resistance is low. Risk is higher with recent use and in older people in residential facilities. [1]
- Second choices apply if there is no improvement after at least 48 hours on a first choice, or if a first choice is unsuitable: - Nitrofurantoin, if not used as the first choice. - Pivmecillinam 400 mg initially, then 200 mg three times daily, for a total of 3 days. - Fosfomycin as a 3 g single-dose sachet. [1]
Antibiotic choice: pregnant women and men
- For pregnant women aged 12 and over, the first choice is nitrofurantoin, if eGFR is 45 ml/minute or more. Give 100 mg modified-release twice daily, or 50 mg four times daily if modified-release is unavailable, for 7 days. Avoid it at term because of the risk of neonatal haemolysis. Trimethoprim is not recommended, as it is contraindicated in pregnancy. [1]
- Second choices in pregnancy apply if there is no improvement after at least 48 hours on the first choice, or if the first choice is unsuitable. The options are: - Amoxicillin, only if culture confirms susceptibility, because resistance rates are high. - Cefalexin. - Other antibiotics advised by a local microbiologist, based on culture results. [1]
- Second-choice doses in pregnancy are amoxicillin 500 mg three times daily or cefalexin 500 mg twice daily. Each is given as a 7-day course. [1]
- First choices for men aged 16 and over, each for 7 days: - Trimethoprim 200 mg twice daily. - Nitrofurantoin, if eGFR is 45 ml/minute or more: 100 mg modified-release twice daily, or 50 mg four times daily if modified-release is unavailable. Nitrofurantoin is not recommended if prostate involvement is suspected, as it is unlikely to reach therapeutic levels in the prostate. [1]
- In men not responding to a first choice, consider alternative diagnoses such as acute pyelonephritis or acute prostatitis. Base the second-line choice on recent culture results. If acute prostatitis is suspected, quinolones are the first choice, following the NICE prostatitis guideline. [1]
Antibiotic choice: children and young people under 16
- Refer infants under 3 months to a paediatric specialist and treat with intravenous antibiotics in line with the NICE fever guideline. [1]
- First choices for children aged 3 months and over use age-banded doses: - Trimethoprim, if resistance risk is low. - Nitrofurantoin, if eGFR is 45 ml/minute or more. If both are appropriate, choose the one with the lower acquisition cost. A 3-day course is sufficient. [1]
- Second choices for children aged 3 months and over apply if there is no improvement after at least 48 hours on a first choice, or if a first choice is unsuitable. The options are: - Nitrofurantoin, if not used as the first choice. - Amoxicillin, only with culture-confirmed susceptibility. - Cefalexin. Children on prophylactic antibiotics should be treated with a different antibiotic, not a higher dose of the same one. [1]
Limitations and use
- Antibiotic choices for acute pyelonephritis, complicated UTI and acute prostatitis are deferred to separate NICE guidelines and are not covered here.
- No second-choice antibiotic regimen is specified for men. The source directs prescribers to consider alternative diagnoses and to base the choice on recent culture and susceptibility results.
- Diagnosis of UTI in under-16s and management of fever in under-5s are deferred to separate NICE guidelines.
- The detailed age-banded paediatric doses in Table 4 are only partly summarised; prescribers should consult the original table and the BNFC. Dosing in hepatic or renal impairment and in breastfeeding is referred to the BNF.
- The evidence for back-up prescribing came only from non-pregnant women aged 18 to 70 years who did not need immediate antibiotics. No back-up prescribing evidence was identified for men, pregnant women, older people or children.
- Research recommendations and later nonclinical rationale and update sections were not included in the reviewed extract.
- Recommendation 1.2.1 was amended in May 2022 to remove the reference to routine screening for asymptomatic bacteriuria in pregnancy.
This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.
Summary sources
- Urinary tract infection (lower): antimicrobial prescribing
Guideline recommendation text consulted
Publication details
- Issuing organisation
- NICE
- First published
- 31 October 2018
- Resource type
- Clinical guideline · House clinical summary
The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.